Associative and predictive biomarkers of dementia in HIV-1-infected patients
about
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosisHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentFingolimod for the treatment of neurological diseases-state of play and future perspectivesCambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective propertiesCeramide-mediated insulin resistance and impairment of cognitive-motor functionsInhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.Designer adiponectin receptor agonist stabilizes metabolic function and prevents brain injury caused by HIV protease inhibitorsQuantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.Blood-based biomarkers of microvascular pathology in Alzheimer's disease.Intercellular Adhesion Molecular-5 as Marker in HIV Associated Neurocognitive Disorder.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection.Deficiency of a Niemann-Pick, type C1-related protein in toxoplasma is associated with multiple lipidoses and increased pathogenicity.Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume lossHeme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disordersMetabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 miceImpact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairmentPlasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging.Elevated plasma ceramides in depressionDisturbance in cerebral spinal fluid sphingolipid content is associated with memory impairment in subjects infected with the human immunodeficiency virusPlasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China.The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.Ceramide metabolism analysis in a model of binge drinking reveals both neuroprotective and toxic effects of ethanol.Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on 18F-FDG-PET.Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairmentAntioxidant sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders.Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.Antiretroviral adherence and the nature of HIV-associated verbal memory impairmentRoles of glutathione in antioxidant defense, inflammation, and neuron differentiation in the thalamus of HIV-1 transgenic rats.Peripheral sphingolipids are associated with variation in white matter microstructure in older adults.Independent and co-morbid HIV infection and Meth use disorders on oxidative stress markers in the cerebrospinal fluid and depressive symptoms.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.
P2860
Q24644684-AB59E230-028F-48CD-BF3E-DF954464C347Q26766448-ED6CF1DF-DD76-49D4-9059-456ABD57C05BQ27026175-3CBE5FE1-B810-4B35-8619-AE1D808781E8Q28547451-5A803D26-5597-4593-872C-900DC65AD145Q30478907-116C392D-F5E6-4972-A19F-09E50F37F24BQ30495972-E3ED1ECC-C2F5-4486-A3FC-790C29AF16FBQ30625328-D74FA219-E745-417B-95B1-A93E002C227DQ33571865-8C1ECE21-C154-47B6-9A3C-CA3D3F1E7990Q33625663-AA5B3B9E-20E6-41EE-8FE1-8DD81909EE38Q33714228-AAE11463-8AE8-41C5-B9DE-947B33E6B9D0Q33863368-A038FA90-F34A-4665-86C5-759A1091A70BQ33938800-41AEA200-C3E9-4A02-8116-DCE197349F8FQ34020587-3AD1C9AF-ABDD-4110-95FE-E693584D57BDQ34037622-B860A3B3-4580-4024-A553-0DE635353617Q34067393-736762C1-1417-40BE-B3A3-C1D32CCBA307Q34102702-61BE5D48-4BF6-4BFD-9011-F1AC885AE47DQ34106300-0F2745B1-38C6-49BA-857A-DB564EDE279BQ34139883-90D18629-3E5F-4537-AF1B-99FC7756B87CQ34311736-C12E325C-CCAB-4391-A500-A3C234F31C06Q34349192-7E10953C-AB21-4429-8973-A9428B0740FCQ34718216-3137EF81-C49A-4818-9C8C-2B76F77D3237Q34994293-EE77172F-C0D8-42F0-9FC3-634D5D30353FQ35027653-7DC32492-C2F0-4253-8364-46261DBD14B6Q35062581-7F1E1EE6-315C-4C2E-8224-908CD0F827B7Q35130214-98891D6C-A743-4BA5-87AF-77DB892124F0Q35175447-9401ABD8-5B4D-484F-A64A-6E2C69A4DECBQ35186413-7A7B6F35-B588-4380-B8F3-8B510FD76743Q35187881-D7A69335-57F0-42A8-AF61-62EF848DFCDBQ35195927-27C3FF92-E583-4739-87D3-F5E962AC9CAEQ35519881-C17E7BC6-EF87-42CE-91FB-3125433C16F7Q35968517-C6DAA9E4-64AA-4D8D-A873-1D09B5CC30FFQ36104280-37477B54-AD9F-491E-A4CB-C7EB857E2F49Q36121837-F520CCC4-9ACB-4CC3-8C2D-678BE901F5A8Q36613921-EDFCF059-171E-4E6A-B865-408B789A485FQ36670527-5BF1DA96-ED95-460A-BA87-509D0D8103AAQ36702134-D9B163DA-C79B-4092-AA65-C843EF1D6AF8Q36904688-8BCB7165-7082-49FB-8316-00A469042C64Q36973077-6FC39B0D-289D-4C54-95F4-534C0E211273Q36988191-02C6A5C0-CB0E-40C4-B078-52238C6B3D8AQ37122279-EE4337AC-CA5B-4D2F-BF0B-C13FA5991F12
P2860
Associative and predictive biomarkers of dementia in HIV-1-infected patients
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@ast
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@en
type
label
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@ast
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@en
prefLabel
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@ast
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@en
P2093
P2860
P1433
P1476
Associative and predictive biomarkers of dementia in HIV-1-infected patients
@en
P2093
J C McArthur
M P Mattson
N J Haughey
R G Cutler
V V R Bandaru
P2860
P304
P356
10.1212/01.WNL.0000260610.79853.47
P407
P577
2007-05-01T00:00:00Z